CCDC150P1

Across TCGA pan-cancer cohorts, CCDC150P1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CCDC150P1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CCDC150P1 RNA is repressed in tumor relative to normal tissue. In most cancer types CCDC150P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA, LIHC, and KICH are the cancer types where CCDC150P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCDC150P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−1.331	<.001	10	view →
LIHC	All	All	+0.271	<.001	8	view →
KICH	All	All	+1.029	<.001	6	view →
LUSC	Male	II,III,IV	+0.860	<.001	6	view →
LUAD	Male	All	+0.781	<.001	6	view →
BRCA	All	All	+0.535	<.001	6	view →
UCEC	All	All	+0.449	.005	6	view →
HNSC	Male	All	+0.474	.003	4	view →
COAD	Female	II,III,IV	+0.207	.007	3	view →
CHOL	Male	All	+0.486	.007	2	view →
KIRP	All	All	+0.330	.032	2	view →
KIRC	Male	IV	+0.235	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CCDC150P1–THCA

Open the THCA breakdown →